US Stock MarketDetailed Quotes

DWTX Dogwood Therapeutics

Watchlist
  • 2.340
  • +0.020+0.86%
Close Dec 20 16:00 ET
  • 2.340
  • 0.0000.00%
Post 20:01 ET
3.12MMarket Cap-0.37P/E (TTM)

Dogwood Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-57.38%2.04M
-34.20%3.02M
-55.38%2.38M
-52.82%3.32M
-52.82%3.32M
-51.10%4.79M
-40.35%4.59M
-53.03%5.33M
-49.81%7.03M
-49.81%7.03M
-Cash and cash equivalents
-57.38%2.04M
-34.20%3.02M
-55.38%2.38M
-52.82%3.32M
-52.82%3.32M
-51.10%4.79M
-40.35%4.59M
-53.03%5.33M
-49.81%7.03M
-49.81%7.03M
Prepaid assets
-49.86%222.59K
-1.57%580.63K
-30.09%792.84K
-36.54%844.94K
-36.54%844.94K
-57.95%443.97K
-55.30%589.88K
-2.53%1.13M
-24.68%1.33M
-24.68%1.33M
Other current assets
10.72%20.84K
9.23%35.07K
-3.11%52.24K
-51.19%3.56K
-51.19%3.56K
37.62%18.82K
26.53%32.11K
58.23%53.92K
744.84%7.29K
744.84%7.29K
Total current assets
-56.50%2.28M
-30.24%3.64M
-50.55%3.22M
-50.23%4.17M
-50.23%4.17M
-51.66%5.25M
-42.34%5.21M
-48.04%6.52M
-46.95%8.37M
-46.95%8.37M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-56.50%2.28M
-30.24%3.64M
-50.55%3.22M
-50.23%4.17M
-50.23%4.17M
-51.66%5.25M
-42.34%5.21M
-48.04%6.52M
-46.95%8.37M
-46.95%8.37M
Liabilities
Current liabilities
Payables
121.53%454.96K
1.61%217.76K
45.65%196.76K
-80.47%111.91K
-80.47%111.91K
-69.77%205.37K
-67.80%214.31K
-59.15%135.09K
61.97%573.16K
61.97%573.16K
-accounts payable
121.53%454.96K
1.61%217.76K
45.65%196.76K
-80.47%111.91K
-80.47%111.91K
-69.77%205.37K
-67.80%214.31K
-59.15%135.09K
61.97%573.16K
61.97%573.16K
Current accrued expenses
274.02%878.86K
-6.83%226.39K
-12.99%279.35K
-20.54%246.64K
-20.54%246.64K
-66.06%234.98K
-72.56%242.99K
-75.49%321.05K
-20.22%310.39K
-20.22%310.39K
Current liabilities
173.80%1.33M
-3.84%500.08K
3.79%570.08K
-65.63%358.55K
-65.63%358.55K
-70.17%487.14K
-72.60%520.03K
-70.74%549.29K
-18.22%1.04M
-18.22%1.04M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
173.80%1.33M
-3.84%500.08K
3.79%570.08K
-65.63%358.55K
-65.63%358.55K
-70.17%487.14K
-72.60%520.03K
-70.74%549.29K
-18.22%1.04M
-18.22%1.04M
Shareholders'equity
Share capital
-94.24%111
49.17%2.78K
5.07%1.93K
5.07%1.93K
5.07%1.93K
5.07%1.93K
123.41%1.86K
120.05%1.83K
120.05%1.83K
120.05%1.83K
-common stock
-94.24%111
49.17%2.78K
5.07%1.93K
5.07%1.93K
5.07%1.93K
5.07%1.93K
123.41%1.86K
120.05%1.83K
120.05%1.83K
120.05%1.83K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-9.48%-66.09M
-7.91%-63.81M
-8.79%-62.76M
-9.43%-61.47M
-9.43%-61.47M
-11.52%-60.37M
-14.70%-59.13M
-20.47%-57.69M
-27.88%-56.17M
-27.88%-56.17M
Paid-in capital
2.93%67.34M
4.88%67.24M
3.22%65.71M
3.27%65.57M
3.27%65.57M
3.27%65.42M
9.23%64.11M
8.71%63.66M
8.68%63.5M
8.68%63.5M
Less: Treasury stock
0.01%299.13K
2.35%299.11K
--299.11K
--299.11K
--299.11K
--299.11K
--292.24K
----
--0
--0
Total stockholders'equity
-80.06%949.43K
-33.17%3.14M
-55.55%2.65M
-48.04%3.81M
-48.04%3.81M
-48.38%4.76M
-34.31%4.69M
-44.05%5.97M
-49.48%7.33M
-49.48%7.33M
Total equity
-80.06%949.43K
-33.17%3.14M
-55.55%2.65M
-48.04%3.81M
-48.04%3.81M
-48.38%4.76M
-34.31%4.69M
-44.05%5.97M
-49.48%7.33M
-49.48%7.33M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -57.38%2.04M-34.20%3.02M-55.38%2.38M-52.82%3.32M-52.82%3.32M-51.10%4.79M-40.35%4.59M-53.03%5.33M-49.81%7.03M-49.81%7.03M
-Cash and cash equivalents -57.38%2.04M-34.20%3.02M-55.38%2.38M-52.82%3.32M-52.82%3.32M-51.10%4.79M-40.35%4.59M-53.03%5.33M-49.81%7.03M-49.81%7.03M
Prepaid assets -49.86%222.59K-1.57%580.63K-30.09%792.84K-36.54%844.94K-36.54%844.94K-57.95%443.97K-55.30%589.88K-2.53%1.13M-24.68%1.33M-24.68%1.33M
Other current assets 10.72%20.84K9.23%35.07K-3.11%52.24K-51.19%3.56K-51.19%3.56K37.62%18.82K26.53%32.11K58.23%53.92K744.84%7.29K744.84%7.29K
Total current assets -56.50%2.28M-30.24%3.64M-50.55%3.22M-50.23%4.17M-50.23%4.17M-51.66%5.25M-42.34%5.21M-48.04%6.52M-46.95%8.37M-46.95%8.37M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -56.50%2.28M-30.24%3.64M-50.55%3.22M-50.23%4.17M-50.23%4.17M-51.66%5.25M-42.34%5.21M-48.04%6.52M-46.95%8.37M-46.95%8.37M
Liabilities
Current liabilities
Payables 121.53%454.96K1.61%217.76K45.65%196.76K-80.47%111.91K-80.47%111.91K-69.77%205.37K-67.80%214.31K-59.15%135.09K61.97%573.16K61.97%573.16K
-accounts payable 121.53%454.96K1.61%217.76K45.65%196.76K-80.47%111.91K-80.47%111.91K-69.77%205.37K-67.80%214.31K-59.15%135.09K61.97%573.16K61.97%573.16K
Current accrued expenses 274.02%878.86K-6.83%226.39K-12.99%279.35K-20.54%246.64K-20.54%246.64K-66.06%234.98K-72.56%242.99K-75.49%321.05K-20.22%310.39K-20.22%310.39K
Current liabilities 173.80%1.33M-3.84%500.08K3.79%570.08K-65.63%358.55K-65.63%358.55K-70.17%487.14K-72.60%520.03K-70.74%549.29K-18.22%1.04M-18.22%1.04M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 173.80%1.33M-3.84%500.08K3.79%570.08K-65.63%358.55K-65.63%358.55K-70.17%487.14K-72.60%520.03K-70.74%549.29K-18.22%1.04M-18.22%1.04M
Shareholders'equity
Share capital -94.24%11149.17%2.78K5.07%1.93K5.07%1.93K5.07%1.93K5.07%1.93K123.41%1.86K120.05%1.83K120.05%1.83K120.05%1.83K
-common stock -94.24%11149.17%2.78K5.07%1.93K5.07%1.93K5.07%1.93K5.07%1.93K123.41%1.86K120.05%1.83K120.05%1.83K120.05%1.83K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -9.48%-66.09M-7.91%-63.81M-8.79%-62.76M-9.43%-61.47M-9.43%-61.47M-11.52%-60.37M-14.70%-59.13M-20.47%-57.69M-27.88%-56.17M-27.88%-56.17M
Paid-in capital 2.93%67.34M4.88%67.24M3.22%65.71M3.27%65.57M3.27%65.57M3.27%65.42M9.23%64.11M8.71%63.66M8.68%63.5M8.68%63.5M
Less: Treasury stock 0.01%299.13K2.35%299.11K--299.11K--299.11K--299.11K--299.11K--292.24K------0--0
Total stockholders'equity -80.06%949.43K-33.17%3.14M-55.55%2.65M-48.04%3.81M-48.04%3.81M-48.38%4.76M-34.31%4.69M-44.05%5.97M-49.48%7.33M-49.48%7.33M
Total equity -80.06%949.43K-33.17%3.14M-55.55%2.65M-48.04%3.81M-48.04%3.81M-48.38%4.76M-34.31%4.69M-44.05%5.97M-49.48%7.33M-49.48%7.33M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List